BlogAugust 2, 2023 Fraser Johnston Inspires Healthy and Cooperative Communities – Podcast Episode #33
PressJuly 31, 2023 Psilocybin Potency, The Missing Link For Magic Mushroom Safety: Oakland’s Psychedelic Mushroom Church Announces Groundbreaking Information for Safe Use of Psilocybin Mushrooms
PressJuly 31, 2023 COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023
PressJuly 28, 2023 Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
PressJuly 28, 2023 Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents
PressJuly 28, 2023 Mind Cure Announces LNG Energy Group Credit Agreement in the Amount of U.S. $70 Million to Acquire Lewis Energy Colombia, Inc.
PressJuly 25, 2023 PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
PressJuly 25, 2023 First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine
PressJuly 25, 2023 Filament Health Announces Upsizing and Closing of $2,500,000 Non-Brokered Private Placement Financing
PressJuly 21, 2023 PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale
PressJuly 20, 2023 Kernel’s Revolutionary Neuroimaging Technology, Flow1, Validated in Published Feasibility Study on Measuring Psychedelic Effects
PressJuly 20, 2023 Filament Health Corp. To List on Nasdaq Through Business Combination With Jupiter Acquisition Corporation
